Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
Current Obstetrics and Gynecology Reports
Published in: Current Obstetrics and Gynecology Reports 2/2021

01-06-2021 | Progesterone | HOT TOPIC

Premature Luteinization May Impact In Vitro Fertilization Outcomes Through Dual Action on Both Uterus and Embryos

Authors: Reda S. Hussein, Elizabeth A Stewart, Yulian Zhao

Published in: Current Obstetrics and Gynecology Reports | Issue 2/2021

Login to get access

Abstract

Purpose of Review

This review aims to provide the up-to-date knowledge of potential mechanisms behind the putative impact of premature luteinization (PL) on the in vitro fertilization (IVF) cycle outcomes and to examine whether PL can affect embryo/oocyte quality.

Recent Findings

There is growing evidence supporting the possible negative effect of PL on the oocyte/embryo quality in various ovarian response categories of IVF cycles.

Summary

It is generally accepted based on prior research that PL could affect pregnancy potential in fresh IVF cycles by impacting endometrial receptivity. PL is usually defined as serum progesterone (P) level equal or greater than 1.5 ng/ml on the day of ovulation triggering. Unfortunately, a way to prevent PL is still lacking. Embryo cryopreservation with deferred transfer in a subsequent cycle is so far the most widely practiced strategy to bypass the PL-induced harm on endometrial receptivity. However, embryo freezing carries an extra burden for both the IVF laboratory and patients and increases IVF cost. Moreover, there are recent reports showing that PL may adversely impact oocyte and embryo quality. It is thus of utmost importance to understand if PL adversely influences eggs and embryos; if this hypothesis is proven to be true, embryo freezing for a subsequent transfer may not improve outcomes and the management of PL may be reconsidered.
Literature
1.
Venetis CA, Kolibianakis EM, Bosdou JK, Lainas GT, Sfontouris IA, Tarlatzis BC, et al. Estimating the net effect of progesterone elevation on the day of hCG on live birth rates after IVF: a cohort analysis of 3296 IVF cycles. Hum Reprod. 2015;30(3):684–91.PubMedCrossRef
2.
Bosch E, Labarta E, Crespo J, Simon C, Remohi J, Jenkins J, et al. Circulating progesterone levels and ongoing pregnancy rates in controlled ovarian stimulation cycles for in vitro fertilization: analysis of over 4000 cycles. Hum Reprod. 2010;25(8):2092–100.PubMedCrossRef
3.
• Venetis C, Kolibianakis E, Bosdou J, Tarlatzis B. Progesterone elevation and probability of pregnancy after IVF: a systematic review and meta-analysis of over 60 000 cycles. Hum Reprod. 2013;19(5):433–57 This is the largest meta-analysis conducted in the topic of PL that showed a clear hostile effect for PL on fresh IVF cycles, yet not on frozen or oocyte donation cycles.
4.
Andersen CY, Bungum L, Andersen AN, Humaidan P. Preovulatory progesterone concentration associates significantly to follicle number and LH concentration but not to pregnancy rate. Reprod Biomed. 2011;23(2):187–95.CrossRef
5.
Seow K-M, Lin Y-H, Hsieh B-C, Huang L-W, Huang S-C, Chen C-Y, et al. Characteristics of progesterone changes in women with subtle progesterone rise in recombinant follicle-stimulating hormone and gonadotropin-releasing hormone antagonist cycle. Gynecol Obstet Invest. 2010;70(1):64–8.PubMedCrossRef
6.
Schoolcraft W, Sinton E, Schlenker T, Huynh D, Hamilton F, Meldrum DR. Lower pregnancy rate with premature luteinization during pituitary suppression with leuprolide acetate. Fertil Steril. 1991;55(3):563–6.PubMedCrossRef
7.
Liu L, Zhou F, Lin X, Li T, Tong X, Zhu H, et al. Recurrent IVF failure is associated with elevated progesterone on the day of hCG administration. Eur J Obstet Gynecol Reprod Biol. 2013;171(1):78–83.PubMedCrossRef
8.
Vickers NJ. Animal communication: when I’m calling you, will you answer too? Curr Biol. 2017;27(14):R713–R5.PubMedCrossRef
9.
Andersen AN, Devroey P, Arce J-C. Clinical outcome following stimulation with highly purified hMG or recombinant FSH in patients undergoing IVF: a randomized assessor-blind controlled trial. Hum Reprod. 2006;21(12):3217–27.PubMedCrossRef
10.
Kolibianakis EM, Albano C, Camus M, Tournaye H, Van Steirteghem AC, Devroey P. Prolongation of the follicular phase in in vitro fertilization results in a lower ongoing pregnancy rate in cycles stimulated with recombinant follicle-stimulating hormone and gonadotropin-releasing hormone antagonists. Fertil Steril. 2004;82(1):102–7.PubMedCrossRef
11.
Bosch E, Valencia I, Escudero E, Crespo J, Simón C, Remohí J, et al. Premature luteinization during gonadotropin-releasing hormone antagonist cycles and its relationship with in vitro fertilization outcome. Fertil Steril. 2003;80(6):1444–9.PubMedCrossRef
12.
• Bu Z, Zhao F, Wang K, Guo Y, Su Y, Zhai J, et al. Serum progesterone elevation adversely affects cumulative live birth rate in different ovarian responders during in vitro fertilization and embryo transfer: a large retrospective study. PLoS One. 2014;9(6):e100011. https://​doi.​org/​10.​1371/​journal.​pone.​0100011A large study that showed a adverse impact for PL on the rate of top-quality embryo formation in the diffent ovarian responders.CrossRefPubMedPubMedCentral
13.
14.
15.
Melo MAB, Meseguer M, Garrido N, Bosch E, Pellicer A, Remohí J. The significance of premature luteinization in an oocyte-donation programme. Hum Reprod. 2006;21(6):1503–7.PubMedCrossRef
16.
Hill MJ, Royster GD IV, Healy MW, Richter KS, Levy G, DeCherney AH, et al. Are good patient and embryo characteristics protective against the negative effect of elevated progesterone level on the day of oocyte maturation? Fertil Steril. 2015;103(6):1477–84.e5.PubMedPubMedCentralCrossRef
17.
Papanikolaou EG, Kolibianakis EM, Pozzobon C, Tank P, Tournaye H, Bourgain C, et al. Progesterone rise on the day of human chorionic gonadotropin administration impairs pregnancy outcome in day 3 single-embryo transfer, while has no effect on day 5 single blastocyst transfer. Fertil Steril. 2009;91(3):949–52.PubMedCrossRef
18.
Bourgain C, Ubaldi F, Tavaniotou A, Smitz J, Van Steirteghem AC, Devroey P. Endometrial hormone receptors and proliferation index in the periovulatory phase of stimulated embryo transfer cycles in comparison with natural cycles and relation to clinical pregnancy outcome. Fertil Steril. 2002;78(2):237–44.PubMedCrossRef
19.
Cetinkaya ES, Berker B, Aytac R, Atabekoglu C, Sonmezer M, Ozmen B. The value of the progesterone-to-estradiol ratio on the day of hCG administration in predicting ongoing pregnancy and live birth rates in normoresponders undergoing GnRH antagonist cycles. Eur J Obstet Gynecol Reprod Biol. 2013;170(2):452–7.PubMedCrossRef
20.
Ubaldi F, Bourgain C, Tournaye H, Smitz J, Van Steirteghem A, Devroey P. Endometrial evaluation by aspiration biopsy on the day of oocyte retrieval in the embryo transfer cycles in patients with serum progesterone rise during the follicular phase. Fertil Steril. 1997;67(3):521–6.PubMedCrossRef
21.
Chetkowski RJ, Kiltz RJ, Salyer WR. In premature luteinization, progesterone induces secretory transformation of the endometrium without impairment of embryo viability. Fertil Steril. 1997;68(2):292–7.PubMedCrossRef
22.
Dickey RP, Olar T, Curole D, Taylor S, Rye P. Endometrial pattern and thickness associated with pregnancy outcome after assisted reproduction technologies. Hum Reprod. 1992;7(3):418–21.PubMedCrossRef
23.
Gingold JA, Lee JA, Rodriguez-Purata J, Whitehouse MC, Sandler B, Grunfeld L, et al. Endometrial pattern, but not endometrial thickness, affects implantation rates in euploid embryo transfers. Fertil Steril. 2015;104(3):620–8.e5.PubMedPubMedCentralCrossRef
24.
Fanchin R, Righini C, Olivennes F, Taieb J, de Ziegler D, Frydman R. Computerized assessment of endometrial echogenicity: clues to the endometrial effects of premature progesterone elevation. Fertil Steril. 1999;71(1):174–81.PubMedCrossRef
25.
Pandurangi M, Reddy NS, Rani GU, Kirubamani H. Does pretrigger echogenic endometrium in assisted reproductive technology cycles reflect raised serum progesterone level? J Hum Reprod Sci. 2018;11(1):29–33.PubMedPubMedCentralCrossRef
26.
Kolibianakis E, Bourgain C, Albano C, Osmanagaoglu K, Smitz J, Van Steirteghem A, et al. Effect of ovarian stimulation with recombinant follicle-stimulating hormone, gonadotropin releasing hormone antagonists, and human chorionic gonadotropin on endometrial maturation on the day of oocyte pick-up. Fertil Steril. 2002;78(5):1025–9.PubMedCrossRef
27.
Van Vaerenbergh I, Fatemi H, Blockeel C, Van Lommel L, Schuit F, Kolibianakis E, et al. Progesterone rise on HCG day in GnRH antagonist/rFSH stimulated cycles affects endometrial gene expression. Reprod Biomed. 2011;22(3):263–71.CrossRef
28.
Labarta E, Martinez-Conejero J, Alama P, Horcajadas J, Pellicer A, Simón C, et al. Endometrial receptivity is affected in women with high circulating progesterone levels at the end of the follicular phase: a functional genomics analysis. Hum Reprod. 2011;26(7):1813–25.PubMedCrossRef
29.
Liu L, Huang J, Li TC, Hong XT, Laird S, Dai YD, et al. The effect of elevated progesterone levels before oocyte retrieval in women undergoing ovarian stimulation for IVF treatment on the genomic profile of peri-implantation endometrium. J Reprod Immunol. 2017;121:17–25.PubMedCrossRef
30.
31.
Haouzi D, Bissonnette L, Gala A, Assou S, Entezami F, Perrochia H, et al. Endometrial receptivity profile in patients with premature progesterone elevation on the day of HCG administration. BioMed Res Int. 2014;2014:951937.PubMedPubMedCentralCrossRef
32.
Talbi S, Hamilton A, Vo K, Tulac S, Overgaard MT, Dosiou C, et al. Molecular phenotyping of human endometrium distinguishes menstrual cycle phases and underlying biological processes in normo-ovulatory women. Endocrinology. 2006;147(3):1097–121.PubMedCrossRef
33.
Li R, Qiao J, Wang L, Li L, Zhen X, Liu P, et al. MicroRNA array and microarray evaluation of endometrial receptivity in patients with high serum progesterone levels on the day of hCG administration. Reprod Biol Endocrinol. 2011;9(1):29.PubMedPubMedCentralCrossRef
34.
Hofmann GE, Bentzien F, Bergh PA, Garrisi GJ, Williams MC, Guzman I, et al. Premature luteinization in controlled ovarian hyperstimulation has no adverse effect on oocyte and embryo quality. Fertil Steril. 1993;60(4):675–9.PubMedCrossRef
35.
Shulman A, Ghetler Y, Beyth Y, Ben-Nun I. The significance of an early (premature) rise of plasma progesterone in in vitro fertilization cycles induced by a “long protocol” of gonadotropin releasing hormone analogue and human menopausal gonadotropins. J Assist Reprod Genet. 1996;13(3):207–11.PubMedCrossRef
36.
Legro R, Ary B, Paulson R, Stanczyk F, Sauer M. Pregnancy: premature luteinization as detected by elevated serum progesterone is associated with a higher pregnancy rate in donor oocyte in-vitro fertilization. Hum Reprod. 1993;8(9):1506–11.PubMedCrossRef
37.
Check JH, Hourani C, Choe JK, Callan C, Adelson HG. Pregnancy rates in donors versus recipients according to the serum progesterone level at the time of human chorionic gonadotropin in a shared oocyte program. Fertil Steril. 1994;61(2):262–4.PubMedCrossRef
38.
Fanchin R, Righini C, Olivennes F, de Ziegler D, Selva J, Frydman R. Premature progesterone elevation does not alter oocyte quality in in vitro fertilization. Fertil Steril. 1996;65(6):1178–83.PubMedCrossRef
39.
Check J, Wilson C, Choe J, Amui J, Brasile D. Evidence that high serum progesterone (P) levels on day of human chorionic gonadotropin (hCG) injection have no adverse effect on the embryo itself as determined by pregnancy outcome following embryo transfer using donated eggs. Clin Exp Obstet Gynecol. 2010;37(3):179–80.PubMed
40.
Silverberg KM, Martin M, Olive DL, Burns WN, Schenken RS. Elevated serum progesterone levels on the day of human chorionic gonadotropin administration in in vitro fertilization cycles do not adversely affect embryo quality. Fertil Steril. 1994;61(3):508–13.PubMedCrossRef
41.
Xu B, Li Z, Zhang H, Jin L, Li Y, Ai J, et al. Serum progesterone level effects on the outcome of in vitro fertilization in patients with different ovarian response: an analysis of more than 10,000 cycles. Fertil Steril. 2012;97(6):1321–7.e4.PubMedCrossRef
42.
Kofinas JD, Mehr H, Ganguly N, Biley Y, Bochkovsky S, McCulloh D, et al. Is it the egg or the endometrium? Elevated progesterone on day of trigger is not associated with embryo ploidy nor decreased success rates in subsequent embryo transfer cycles. J Assist Reprod Genet. 2016;33(9):1169–74.PubMedPubMedCentralCrossRef
43.
Baldini D, Savoia M, Sciancalepore A, Malvasi A, Vizziello D, Beck R, et al. High progesterone levels on the day of HCG administration do not affect the embryo quality and the reproductive outcomes of frozen embryo transfers. La Clinica Terapeutica. 2018;169(3):e91–e5.PubMed
44.
Nagai T, Ding J, Moor R. Effect of follicle cells and steroidogenesis on maturation and fertilization in vitro of pig oocytes. J Exp Zool. 1993;266(2):146–51.PubMedCrossRef
45.
Urrego R, Herrera-Puerta E, Chavarria N, Camargo O, Wrenzycki C, Rodriguez-Osorio N. Follicular progesterone concentrations and messenger RNA expression of MATER and OCT-4 in immature bovine oocytes as predictors of developmental competence. Theriogenology. 2015;83(7):1179–87.PubMedCrossRef
46.
O'Shea LC, Mehta J, Lonergan P, Hensey C, Fair T. Developmental competence in oocytes and cumulus cells: candidate genes and networks. Syst Biol Reprod Med. 2012;58(2):88–101.PubMedCrossRef
47.
48.
Harada T, Yoshida S, Katagiri C, Takao N, Ikenari T, Toda T, et al. Endocrinology: reduced implantation rate associated with a subtle rise in serum progesterone concentration during the follicular phase of cycles stimulated with a combination of a gonadotrophin-releasing hormone agonist and gonadotrophin. Hum Reprod. 1995;10(5):1060–4.PubMedCrossRef
49.
Harada T, Katagiri C, Takao N, Toda T, Mio Y, Terakawa N. Altering the timing of human chorionic gonadotropin injection according to serum progesterone (P) concentrations improves embryo quality in cycles with subtle P rise. Fertil Steril. 1996;65(3):594–7.PubMedCrossRef
50.
51.
•• Racca A, Santos-Ribeiro S, De Munck N, Mackens S, Drakopoulos P, Camus M, et al. Impact of late-follicular phase elevated serum progesterone on cumulative live birth rates: is there a deleterious effect on embryo quality? Hum Reprod. 2018;33(5):860–8 A large study investigated cumulative live birth rate and a subgroup analysis of embryo utilization rate according the embryo developmental stages. Embryo utilization rate was significantly lower for both cleavage and blastocyst stages in patients with PL with a more profound effect on the slow growing blastocysts (day 6) than these of day 5.PubMedCrossRef
52.
Healy MW, Yamasaki M, Patounakis G, Richter KS, Devine K, DeCherney AH, et al. The slow growing embryo and premature progesterone elevation: compounding factors for embryo-endometrial asynchrony. Hum Reprod. 2017;32(2):362–7.PubMedPubMedCentralCrossRef
53.
•• Simon C, Branet L, Moreau J, Gatimel N, Cohade C, Lesourd F, et al. Association between progesterone to number of mature oocytes index and live birth in GnRH antagonist protocols. Reprod BioMed. 2019; 38(6):901–7. This was the first study to propose the progesterone to mature oocyte index as an indicator of significant predictiblity for the PL impact on fresh ICSI cycles outcomes.
Metadata
Title
Premature Luteinization May Impact In Vitro Fertilization Outcomes Through Dual Action on Both Uterus and Embryos
Authors
Reda S. Hussein
Elizabeth A Stewart
Yulian Zhao
Publication date
01-06-2021
Publisher
Springer US
Keyword
Progesterone
Published in
Current Obstetrics and Gynecology Reports / Issue 2/2021
Electronic ISSN: 2161-3303
DOI
https://doi.org/10.1007/s13669-021-00304-5